The Marque The Marque
The Marque
About Services Profiles Press Contact

Reshma Kewalramani

CEO & President

Vertex Pharmaceuticals

Boston, MA, USA

Reshma Kewalramani
Kerry Kennedy
RFK / Robert F. Kennedy Human Rights
Robert Kilgour
Dow Investments Plc

Reshma Kewalramani’s Biography

Dr. Reshma Kewalramani, M.D. FASN is a distinguished medical doctor and leader in biotech, who is at the helm of Vertex Pharmaceuticals as CEO and President.

Dr. Kewalramani transitioned to the role of CEO and President on April 1, 2020. A highly experienced medical doctor, clinician, researcher and nephrologist, she is well equipped to lead Vertex into its next stage of growth.

She previously held the positions of Executive Vice President, Chief Medical Officer and Senior Vice President. During her time at Vertex, the company has pioneered ground-breaking medical treatments for cystic fibrosis, namely SYMDEKO/SYMKEVI and TRIKAFTA/KAFTRIO, bringing these transformative new therapies to the majority of CF patients around the world.

Formerly, Dr. Kewalramani spent more than 12 years at Amgen in several senior roles, notably as Vice President, Head US Medical Organization. During this time, Dr. Kewalramani expanded Amgen’s Research and Development unit and established the US Medical Organization which oversaw molecular responsibilities.

A passionate doctor, teacher, mentor, philanthropist and STEM advocate, Dr. Kewalramani is active in her community. Amongst many of her other roles and responsibilities, she is a Fellow of the American Society of Nephrology, a board member of the Biomedical Science Careers Program, a member of the Dean’s Advisory Committee at Boston University Medical School, and a board member of RIZE Massachusetts.

Dr. Kewalramani completed her internship and residency at several Mass General Brigham medical centers, including as Resident Physician at Massachusetts General Hospital.

Throughout her notable career, she has earned several accolades, most recently as a leading CEO of a Fortune 500 biotech company and as an International Institute of New England Golden Door Award Honoree.

Dr. Kewalramani is an alumnus of Harvard Business School and holds a Summa Cum Laude medical degree from Boston University School of Medicine.

Reshma Kewalramani’s Newsfeed

Markets Insider
Vertex CEO Reshma Kewalramani, MD to join Ginkgo Bioworks Board of Directors

Dr. Kewalramani will join the Board of Directors for Ginkgo Bioworks, Inc. after she has been recognized for her work in innovating the pharmaceutical industry. 

Endpoints News
Inside Vertex 3.0: Can Reshma Kewalramani repeat one of biotech's biggest success stories?

Dr. Kewalramani speaks on the difficulties for her first days as CEO of Vertex in the middle of a global pandemis, as well as her plans for the company's success in the future.

View allHide

Reshma Kewalramani’s Background

Vertex Pharmaceuticals
CEO & President
Apr 2020 - Present
Boston, MA, USA
Vertex Pharmaceuticals is a leading biotechnology company that invests in scientific innovation to create transformative new medicines. Dr. Kewalramani was previously the Chief Medical Officer and Executive Vice President of Global Medicines Development and Medical Affairs from April 2018 through March 2020.
Vice President, Head US Medical Organization
Jun 2004 - Jul 2017
Thousand Oaks, CA, USA
Dr. Kewalramani gained experience in several roles at Amgen, notably, Vice President, Head US Medical Organization; Vice Present, Head Nephrology and Metabolic Therapeutic Area, Global Clinical Development; and other various roles across Global Clinical Development and Medical Affairs.
View allHide

Reshma Kewalramani’s Gallery

Board Positions

Ginkgo Bioworks, Inc.
Board Member
Aug 2021 - Present
Boston, MA, USA
Ginkgo Bioworks, a private analytics company, utilizes advanced technology to program cells to produce unique products across a range of industries. Ginkgo is also an active supporter of COVID-19 response efforts.
Vertex Pharmaceuticals
Board Member
Apr 2020 - Present
Boston, MA, USA
As part of her role as CEO and President, Reshma Kewalramani also serves on the Board of Directors.
View allHide

Advisory Roles

Boston University School of Medicine
Advisory Board
Boston, MA, USA
Reshma Kewalramani is a member of the Boston University Medical School's Dean's Advisory Committee. Her role is to assist the board on curricula and appointments made at the Medical School.

Previous Board Positions

Kidney Health Institute
Board Member
Boston, MA, USA
Dr. Kewalramani was previously appointed to the inaugural Board of Directors at the Kidney Health Institute.


Vertex's CF drugs drive 18% growth as company looks to diversify
Jul 2021
Reshma Kewalramani, CEO & President of Vertex Pharmaceuticals, is quoted in this article that discusses Vertex's significant growth and internal investment strategy. "You have never seen us invest more in our internal innovation," Reshma says.
Meet the new Fortune 500 CEO's
Jun 2021
New York, NY, USA
Dr. Kewalramani is mentioned on Fortune's list of the 500 new CEOs for her position at Vertex Pharmaceuticals.
View allHide

Awards & Endorsements

San Francisco, CA, USA
Indiaspora is a platform highlighting the successes of individuals who have left the homeland and have achieved excellence in their field internationally. Dr. Kewalramani was mentioned as part of the Inaugural Business Leaders List 2021.
International Institute of New England
Golden Door Honoree
Apr 2021
Boston, MA, USA
The International Institute of New England honored Reshma Kewalramani with the Golden Door Award, honoring her work in the medical field.
View allHide

Training & Management Courses

Harvard Business School Executive Education
Training and Management
Boston, MA, USA
The General Management Program offers a multi-faceted approach to executive business leadership, offering students innovative approaches to business in the 21st century.


American Society of Nephrology
Washington, DC, USA
Dr. Kewalramani is board certified in internal medicine and nephrology with The American Society of Nephrology.

Reshma Kewalramani’s Education

Boston University School of Medicine logo Boston University School of Medicine logo
Boston University School of Medicine
Doctor of Medicine (M.D)/ Summa Cum Laude
1990 - 1998
Boston University
Liberal Arts/Medical Education Program; Doctor of Medicine (M.D)
1990 - 1998
View allHide